Document is current
Any future updates will be listed below
-
Authors
Patel, Areeba https://orcid.org/0000-0003-0374-4227
Göbel, Kirsten https://orcid.org/0009-0006-2117-6381
Ille, Sebastian
Hinz, Felix
Schoebe, Natalie
Bogumil, Henri
Meyer, Jochen
Brehm, Michelle
Kardo, Helin
Schrimpf, Daniel
Lomakin, Artem
Ritter, Michael
Göller, Pauline
Kerbs, Paul https://orcid.org/0000-0001-5525-1374
Pfeifer, Lisa https://orcid.org/0009-0009-5520-9438
Hamelmann, Stefan
Blume, Christina
Ippen, Franziska M.
Berghaus, Natalie
Euskirchen, Philipp https://orcid.org/0000-0002-9138-805X
Schweizer, Leonille
Hultschig, Claus https://orcid.org/0009-0003-1178-8999
Van Roy, Nadine
Van Dorpe, Jo https://orcid.org/0000-0001-8175-2930
Van der Meulen, Joni
Loontiens, Siebe https://orcid.org/0000-0002-4602-4580
Dedeurwaerdere, Franceska https://orcid.org/0000-0003-4608-1101
Leske, Henning
Halldórsson, Skarphéðinn
Fox, Graeme
Deacon, Simon
Cahyani, Inswasti https://orcid.org/0000-0002-1171-3255
Holmes, Nadine
Wibowo, Satrio
Munro, Rory
Martin, Dan
Sharif, Abid
Housley, Mark
Goldspring, Robert
Brandner, Sebastian https://orcid.org/0000-0002-9821-0342
Roy, Somak
Hench, Jürgen
Frank, Stephan https://orcid.org/0000-0001-6165-0187
Unterberg, Andreas
Goidts, Violaine
Jäger, Natalie https://orcid.org/0000-0002-9589-7580
Paine, Simon https://orcid.org/0000-0002-1434-3931
Smith, Stuart https://orcid.org/0000-0002-4556-2707
Herold-Mende, Christel https://orcid.org/0000-0002-1915-745X
Wick, Wolfgang https://orcid.org/0000-0002-6171-634X
Pfister, Stefan M. https://orcid.org/0000-0002-5447-5322
Vik-Mo, Einar O. https://orcid.org/0000-0001-8303-4123
von Deimling, Andreas https://orcid.org/0000-0002-5863-540X
Krieg, Sandro https://orcid.org/0000-0003-4050-1531
Jones, David TW
Loose, Matthew
Schlesner, Matthias https://orcid.org/0000-0002-5896-4086
Sill, Martin https://orcid.org/0000-0001-7616-7665
Sahm, Felix https://orcid.org/0000-0001-5441-1962
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC1389, CRC1389, CRC1389, CRC1389, CRC1389, CRC1389)
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 4 February 2025
First Online: 25 March 2025
Competing interests
: M. Sill, S.M.P., A.v.D., D.T.W.J., D.S. and F.S. are co-founders and shareholders of Heidelberg Epignostix GmbH. A.P. became a full-time employee of Heidelberg Epignostix GmbH in December 2024, while N.J. and M. Sill joined as full-time employees in July 2024, and D.S. became a part-time employee in November 2024. M.L. was a member of the Oxford Nanopore Technologies MinION access program and previously received free flow cells and sequencing reagents. M.L., S.H., H.L. and E.O.V.M. have received reimbursement for travel, accommodation and conference fees to speak at events organized by ONT. A.P., H.K., S.M.P., A.v.D., D.T.W.J., M.L., M. Sill and F.S. are inventors on a patent application related to a nanopore sequencing-based method for cancer characterization, filed by Deutsches Krebsforschungszentrum (DKFZ), Universität Heidelberg, and Oxford Nanopore Technologies PLC (patent application number: 18682016). The other authors declare no competing interests.
